Article
[2-5 AS activity in serum and peripheral blood mononuclear cells for chronic active hepatitis C and the relationship to clinical outcome of interferon therapy].
Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology - 1 Oct 1997
Toda K, Kumagai N, Iwabuchi N, Suzuki T, Saito H, Morizane T, Hibi T, Ishii H, Tsuchimoto K
Abstract excerpt
Of 49 patients with chronic hepatitis C treated by interferon (IFN), we measured 2'-5'-oligoadenylate synthetase (2-5 AS) activity in peripheral blood mononuclear cells (PBMC) and serum before and after the IFN therapy and studied the correlation with the clinical outcome. Before IFN therapy, the...
Topics
- 2',5'-Oligoadenylate Synthetase
- Antiviral Agents
- Biomarkers
- Cells, Cultured
- Genotype
- Hepacivirus
- Hepatitis C, Chronic
- Humans
- Interferons
- Leukocytes, Mononuclear
- Treatment Outcome